WHO Drug Information Vol. 14, No. 2, 2000
(2000; 73 pages)

Índice de contenido

	Preface
	General Policy Issues
		Generic drugs: the hidden issues of quality and cost
	Personal Perspectives
		Pharmaceutical policies and regulatory control
	Reports on Individual Drugs
		New use for artemether in schistosomiasis
		Clopidogrel and thrombotic thrombocytopenic purpura
		Statins: benefit in cardiovascular disease extended to bone fracture
		Cholera: can rehydration therapy be improved?
		Antibiotics, E. coli and haemolytic-uraemic syndrome
		Orlistat associated with hypertension
	Current Topics
		Interagency Task Team on Access to HIV-Related Drugs
	Regulatory and Safety Matters
		Pneumococcal vaccine: recommendations for use
		Valaciclovir: neuropsychiatric reactions
		Zanamivir: revisions to labelling
		Celecoxib: adverse reaction reports
		Olanzapine: serious reactions
		Infliximab approved for rheumatoid arthritis
		Tenecteplase: the first "clot buster"
		Bupropion: a new approach to smoking cessation
		Doxorubicin for ovarian cancer
		Linezolid: the first oxazolide antimicrobial approved
		Guidance for adverse reactions labelling
		Legislation adopted in Europe on orphan drugs
		More drug safety measures planned in Japan
		"Street drug alternatives" are not dietary supplements
		Tamsulosin: syncope now reported
		Dapsone hypersensitivity syndrome
		Kava extract linked to hepatitis
		Gene therapy and patient protection
	Essential Drugs - WHO Model Prescribing Information
		Streptococcal pharyngitis and prevention of rheumatic fever
		Benzathine benzylpenicillin
		Phenoxymethylpenicillin
		Erythromycin
		Sulfadiazine or sulfisoxazole
	Recent Publications and Sources of Information
		Emergency contraception
		UN Consolidated List: restrictions in use and availability
		New antituberculosis drug development
		Carcinogenic risks from antiviral and antineoplastic drugs
		HIV preventive vaccine research: ethical considerations
	Proposed International Nonproprietary Names: List 83
	Selected WHO Publications of Related Interest

WHO Drug Information Vol. 14, No. 2, 2000

PROPOSED INN LIST 83
INTERNATIONAL NONPROPRIETARY NAMES
FOR PHARMACEUTICAL SUBSTANCES

WORLD HEALTH ORGANIZATION • GENEVA